Australian Clinical Labs
ACL.AX
#7129
Rank
S$0.51 B
Marketcap
$2.60
Share price
2.64%
Change (1 day)
19.36%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: $0.15

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is $0.15. In 2023 the company made an earnings per share (EPS) of $0.15 a decrease over its 2022 EPS that were of $0.80.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023$0.15-80.55%
2022$0.80104.3%
2021$0.39